@windhamvp

Novocure Receives Reimbursement Approval for Optune® in Japan for the Treatment of Newly Diagnosed Glioblastoma

Japan represents the largest medical device market in which Novocure has received governmental reimbursement for Optune for the treatment of newly diagnosed glioblastoma ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ:NVCR) announced … Continued

Teleflex to buy NeoTract for up to $1.1 billion in cash and potential milestone payments

Teleflex Inc. TFX, +0.78% said Tuesday it will buy medical device company NeoTract Inc. in a deal valued at up to $1.1 billion. Under terms of the deal, Teleflex will pay $725 million … Continued

Cartiva, Inc., Announces Multiple Presentations at American Orthopaedic Foot and Ankle Society Annual Meeting 2017

(Alpharetta, GA,) – Cartiva, Inc. (Company), a developer of innovative products for treating cartilage damage and osteoarthritis, announced today that clinical data on its Cartiva Synthetic Implant (SCI) will be … Continued

Nuvaira Announces Enrollment Completion in First Sham-Controlled Clinical Trial of Targeted Lung Denervation for COPD

Minneapolis, Minn., – Nuvaira (formerly known as Holaira), a developer of medical devices to treat obstructive lung diseases, today announced completion of patient enrollment in the AIRFLOW-2 trial, the first sham-controlled clinical trial of Targeted … Continued

Holaira Announces Company Name Change to Nuvaira

Minneapolis, Minn., – Holaira, a developer of medical devices to treat obstructive lung diseases, today announced that it has changed its name to Nuvaira, effective immediately. In addition, the company … Continued